86 related articles for article (PubMed ID: 2192573)
1. [The effect of continuous arteriovenous hemofiltration on the pharmacokinetics of azlocillin in anuric patients].
Krupp A; Leuwer M; Schmidt H; Eberhardt B
Anaesthesist; 1990 May; 39(5):275-8. PubMed ID: 2192573
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration.
Joos B; Schmidli M; Keusch G
Nephrol Dial Transplant; 1996 Aug; 11(8):1582-5. PubMed ID: 8856215
[TBL] [Abstract][Full Text] [Related]
4. Nitrogen and amino acid balance during total parenteral nutrition and continuous arteriovenous hemofiltration in critically ill anuric children.
Kuttnig M; Zobel G; Ring E; Grubbauer HM; Kurz R
Child Nephrol Urol; 1991; 11(2):74-8. PubMed ID: 1756524
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of cisplatin in an anuric patient undergoing hemofiltration dialysis.
Gouyette A; Lemoine R; Adhemar JP; Kleinknecht D; Man NK; Droz JP; Macquet JP
Cancer Treat Rep; 1981; 65(7-8):665-8. PubMed ID: 7195773
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intravenous cefuroxime during intermittent and continuous arteriovenous hemofiltration.
Weiss LG; Cars O; Danielson BG; Grahnen A; Wikström B
Clin Nephrol; 1988 Nov; 30(5):282-6. PubMed ID: 3214972
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of azlocillin in healthy subjects.
Leroy A; Humbert G; Fillastre JP
Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
[TBL] [Abstract][Full Text] [Related]
8. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
Haen E; Remien J; Richter E; Frank U; Adam D
Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cefpirome during continuous venovenous hemofiltration: rationale for an 8-hour dosing interval.
Banyai M; Thalhammer F; El-Menyawi I; Heinz G; Traunmüller F; Siostrzonek P
Clin Pharmacol Ther; 2000 Apr; 67(4):368-72. PubMed ID: 10801245
[TBL] [Abstract][Full Text] [Related]
10. [Extrarenal elimination procedures in acute kidney failure].
Sold M
Anaesthesist; 1990 Nov; 39(11):569-86. PubMed ID: 2288406
[TBL] [Abstract][Full Text] [Related]
11. Multiple-dose pharmacokinetics of piperacillin and azlocillin in 12 healthy volunteers.
Tartaglione TA; Nye L; Vishniavsky N; Poynor W; Polk RE
Clin Pharm; 1986 Nov; 5(11):911-6. PubMed ID: 3780161
[TBL] [Abstract][Full Text] [Related]
12. Extrarenal clearance, distribution volume, and elimination rate of digoxin and metildigoxin in anuric patients.
Twittenhoff WD; Strauch M; Kütemeyer M; Koch K; Schaumann W
Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):405-8. PubMed ID: 7298247
[TBL] [Abstract][Full Text] [Related]
13. [The pharmacokinetics of azlocillin after single and multiple intravenous injections during the third trimester].
Voigt R; Weidt I; Schröder S; Brandstädt A; Peiker G
Zentralbl Gynakol; 1988; 110(15):944-8. PubMed ID: 3055753
[TBL] [Abstract][Full Text] [Related]
14. Continuous hemofiltration in patients with acute renal failure.
Jerin L; Zuban F; Ladavac R; Bulić O
Acta Med Croatica; 1995; 49(4-5):211-3. PubMed ID: 8630456
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration.
Langenecker SA; Felfernig M; Werba A; Mueller CM; Chiari A; Zimpfer M
Crit Care Med; 1994 Nov; 22(11):1774-81. PubMed ID: 7956281
[TBL] [Abstract][Full Text] [Related]
16. Single-dose kinetics of imipenem/cilastatin during continuous arteriovenous haemofiltration in intensive care patients.
Keller E; Fecht H; Böhler J; Schollmeyer P
Nephrol Dial Transplant; 1989; 4(7):640-5. PubMed ID: 2510062
[TBL] [Abstract][Full Text] [Related]
17. Continuous veno-venous hemofiltration for the treatment of contrast-induced acute renal failure after percutaneous coronary interventions.
Marenzi G; Bartorelli AL; Lauri G; Assanelli E; Grazi M; Campodonico J; Marana I
Catheter Cardiovasc Interv; 2003 Jan; 58(1):59-64. PubMed ID: 12508197
[TBL] [Abstract][Full Text] [Related]
18. Urea removal by hemofiltration and hemodiafiltration.
Gouyon JB; Petion AM; Huet F; Lallemant C
Biol Neonate; 1994; 65(1):36-40. PubMed ID: 8117843
[TBL] [Abstract][Full Text] [Related]
19. Continuous arteriovenous and intermittent hemofiltration in renal failure.
Alarabi AA
Scand J Urol Nephrol Suppl; 1990; 127():1-55. PubMed ID: 2255868
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics after discontinuous intravenous administration of azlocillin].
Naber K; Adam D
Arzneimittelforschung; 1983; 33(3):429-32. PubMed ID: 6683518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
